Skip to content
Boost Up Blog – Lifestyle
Author:
Femasys Inc.
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
August 26, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 24, 2026
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
April 16, 2026
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
April 1, 2026
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
April 1, 2026
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
March 18, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026